Skip to main content

Evaluation of Ethanol, 2-[2-(2-methoxyethoxy)ethoxy]-, 1,1',1''-triester with boric acid (H3BO3)

This consultation is now closed. 

There is a second consultation now open.

See Executive Director decisions on requests to vary the draft report

AICIS has evaluated Ethanol, 2-[2-(2-methoxyethoxy)ethoxy]-, 1,1',1''-triester with boric acid (H3BO3), CAS No: 30989-05-0 under Part 4 of the Industrial Chemicals Act 2019 (IC Act), in accordance with the Industrial Chemicals (Consequential Amendments and Transitional Provisions) Rules 2019 (Transitional Rules).

This evaluation was previously declared a secondary notification by NICNAS in the February 2020 Chemical Gazette under our old law, the Industrial Chemicals (Assessment and Notification) Act 1989. We are releasing the draft evaluation report for public comment in accordance with section 66 of the Transitional Rules.

Under section 60 of the Transitional Rules, secondary notification assessments started under the old law and not finalised by 1 July 2020, become Evaluations (IC Act). 

Download the draft evaluation report

Why the chemical needed an evaluation

The chemical required an evaluation because:

  • of a new developmental toxicity study that was not available at the time of the assessment as a new chemical, and
  • based on the new study, the notified chemical may be classified as a hazardous substance. 

About the evaluation report

The report is an evaluation of the relevant new information on the potential human health hazard and risks that may be associated with exposure to the chemical.

Evaluation findings - report recommendations

Based on the evaluation findings, the chemical is classified according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) as below:

  • Toxic to Reproduction (Category 2): H361D - suspected of damaging the unborn child

It is recommended that importers revise the SDS and labels to reflect the amended classification.

It is also recommended that users of the chemical should:

  • avoid contact during pregnancy/while nursing
  • avoid contact with skin and eyes

Request for variation applications

Variation requests closed on 6 August.


If you have questions about the public comment process or you wish to discuss the report’s findings and conclusions, please contact us or phone 02 8577 8820.

Published date
Was this page helpful?
For broken links or technical issues, please provide as much detail as possible. Do not include your name, email address and other personal or commercially sensitive information.

Keep informed with updates